Evidence-based, actionable monitoring information to optimise drug treatment

Drug Monitoring Checker is an essential tool to support healthcare professionals make effective drug monitoring decisions at the point of care.

Authored in collaboration with external experts, Drug Monitoring Checker provides clear, concise, and actionable advice before, during and after treatment.

Contact Sales Content Updates
Use case content image

Tailored for use in primary and secondary care settings, the Drug Monitoring Checker provides:

  • Clear rationale
  • Defined frequencies
  • Indication-specific monitoring advice
  • Parameter Profiles to guide interpretation of results
  • Evidence-graded recommendations to aid decision-making
  • Actionable advice for abnormal results
  • Time-saving, easy to search guidance
  • Multiple routes of administration
image above stats

Learn how to monitor a patient with severe hypertension, using new practical information and guidance available through MedicinesComplete

 

Download patient case study

 

150+

drug specific monographs

20+

parameter profiles

Updated

monthly

Publication Updates

10 Jan
Drug Monitoring Checker January 2023 Update

This update contains 4 new monographs.

New monographs: Ciprofloxacin; Fluconazole; Isavuconazole; Levofloxacin.

06 Dec
Drug Monitoring Checker December 2022 Update

This update contains 4 new monographs, and 5 minor updates.

New monographs: Canagliflozin; Dapagliflozin; Empagliflozin; Ertugliflozin.

Minor updates: Amitriptyline hydrochloride; Dosulepin hydrochloride; Doxepin; Imipramine hydrochloride; Nortriptyline.

08 Nov
Drug Monitoring Checker November 2022 Update

This update contains 4 new monographs, and 3 minor updates.

New monographs: Insulin; Gliclazide; Metformin hydrochloride; Tolbutamide

Minor updates: Cimetidine; Famotidine; Nizatidine

11 Oct
Drug Monitoring Checker October 2022 Update

This update contains 5 new monographs, and 2 new parameter profiles.

New monographs: Alogliptin; Linagliptin; Sitagliptin; Saxagliptin; Vildagliptin.

New parameter profiles: Glucose level; HbA1c.

13 Sep
Drug Monitoring Checker September 2022 Update

This update contains 5 new monographs, and 14 minor updates.

New monographs: Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole sodium.

Minor updates: Clobazam; Ethosuximide; Galantamine; Lamotrigine; Levetiracetam; Lithium carbonate; Rivastigmine; Sodium valproate; Tiagabine; Valproic acid; Venlafaxine; Vigabatrin; Zonisamide; Zopiclone.

09 Aug
Drug Monitoring Checker August 2022 Update

This update contains 4 new monographs and 5 minor updates.

New monographs: Eslicarbazepine acetate; Perampanel; Primidone; Rufinamide.

Minor updates: Carbamazepine; Oxcarbazepine; Phenobarbital; Phenytoin; Topiramate.

View more View all content updates